Bracco Imaging has acquired 2 companies.
Bracco Imaging’s largest acquisition to date was in 2019, when it acquired Blue Earth Diagnostics for $475M. Bracco Imaging has acquired in 2 countries. The Company’s most targeted sectors include healthcare services (50%) and medical products (50%).
Via Egidio Folli, 50,
Milan,
20134
Italy,
39 02 217 71
www.braccoimaging.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2019-06-27 |
Blue Earth Diagnostics Ltd. · Medical Products
Oxford, United Kingdom · www.blueearthdiagnostics.com Blue Earth Diagnostics Ltd. is a healthcare company, provides Axumin® (fluciclovine F 18) injection is a novel molecular imaging agent approved in the United States and the European Union for use in PET imaging for men with suspected recurrent prostate cancer. |
475 | Add-on Acquisition |
Bracco Imaging S.p.A.
|
- |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
